Semler Scientific, Inc. (NASDAQ:SMLR) Sees Significant Drop in Short Interest

Semler Scientific, Inc. (NASDAQ:SMLR) saw a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 1,180,000 shares, a drop of 15.1% from the December 31st total of 1,390,000 shares. Based on an average daily trading volume, of 730,200 shares, the short-interest ratio is currently 1.6 days. Approximately 15.7% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital boosted their target price on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research report on Friday, January 24th.

Semler Scientific Stock Performance

Shares of NASDAQ:SMLR traded down $0.19 during trading on Friday, hitting $51.96. 253,355 shares of the stock were exchanged, compared to its average volume of 465,267. The company’s fifty day simple moving average is $59.98 and its 200-day simple moving average is $40.93. The company has a market capitalization of $481.67 million, a price-to-earnings ratio of 25.35 and a beta of 1.18. Semler Scientific has a 1-year low of $20.88 and a 1-year high of $81.56.

Semler Scientific (NASDAQ:SMLR) last posted its earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million for the quarter.

Institutional Trading of Semler Scientific

Large investors have recently added to or reduced their stakes in the company. Newbridge Financial Services Group Inc. bought a new stake in Semler Scientific during the 2nd quarter worth about $34,000. Quest Partners LLC grew its stake in shares of Semler Scientific by 48.0% during the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after purchasing an additional 817 shares during the last quarter. Global Retirement Partners LLC increased its holdings in shares of Semler Scientific by 62.5% in the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock valued at $70,000 after purchasing an additional 500 shares in the last quarter. US Bancorp DE raised its position in Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock worth $72,000 after purchasing an additional 1,158 shares during the last quarter. Finally, Sanctuary Advisors LLC acquired a new position in Semler Scientific during the 3rd quarter worth $104,000. 49.37% of the stock is owned by institutional investors.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.